THERABANK Trademark

Trademark Overview


On Tuesday, January 22, 2008, a trademark application was filed for THERABANK with the United States Patent and Trademark Office. The USPTO has given the THERABANK trademark a serial number of 77377366. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, January 4, 2010. This trademark is owned by TheraGenetics Limited. The THERABANK trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Consulting and advisory services relating to diagnostic preparations and products, namely, prediction of response of individuals to pharmaceutical products and treatments for diseases and disorders of the central nervous system and psychiatric diseases and disorders; Consulting and advisory services relating to diagnostic preparations and products, namely, development, testing and efficacy of pharmaceutical preparations and products for the treatment of diseases and disorders of the central nervous system and psychiatric diseases and disorders; Consulting and advisory services relating to diagnostic preparations and products, namely, provision of goods containing reagents for use in the collection and testing of DNA, RNA and bodily tissues; Consulting and advisory services relating to diagnostic apparatus and diagnostic instruments, namely, prediction of response of individuals to pharmaceutical products and treatments for diseases and disorders of the central nervous system and psychi...

Medical diagnostic services; Medical diagnostic testing relating to the human body, namely, analysis of samples to predict response of individuals to pharmaceutical products and treatments for disorders of the central nervous system and psychiatric diseases and disorders; Medical diagnostic testing relating to the human body, namely, analysis of samples to confirm diagnosis of diseases and disorders of the central nervous system and psychiatric diseases and disorders; Medical clinical services, namely, analysis of samples of DNA, RNA and bodily tissues to prescribe the prescribe the most efficient and/or efficacious pharmaceutical product to the patient; Medical clinical services, namely, the taking of samples of bodily tissues for analysis in connection with the prescription of pharmaceuticals or other medical treatment; Medical and scientific research in the nature of conducting clinical trials; Compilation of medical reports relating to prediction of response of individuals to pharm...
therabank

General Information


Serial Number77377366
Word MarkTHERABANK
Filing DateTuesday, January 22, 2008
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, January 4, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesConsulting and advisory services relating to diagnostic preparations and products, namely, prediction of response of individuals to pharmaceutical products and treatments for diseases and disorders of the central nervous system and psychiatric diseases and disorders; Consulting and advisory services relating to diagnostic preparations and products, namely, development, testing and efficacy of pharmaceutical preparations and products for the treatment of diseases and disorders of the central nervous system and psychiatric diseases and disorders; Consulting and advisory services relating to diagnostic preparations and products, namely, provision of goods containing reagents for use in the collection and testing of DNA, RNA and bodily tissues; Consulting and advisory services relating to diagnostic apparatus and diagnostic instruments, namely, prediction of response of individuals to pharmaceutical products and treatments for diseases and disorders of the central nervous system and psychiatric diseases and disorders; Consulting and advisory services relating to diagnostic apparatus and diagnostic instruments namely, development, testing and efficacy, of apparatus and diagnostic instruments for the treatment of diseases and disorders of the central nervous system and psychiatric diseases and disorders; Consulting and advisory services relating to diagnostic apparatus and diagnostic instruments, namely, provision of assays or assay kits for use in the collection and testing of DNA, RNA and bodily tissues; Design and control of pharmacogenetic diagnostic tests for prediction of response of individuals to pharmaceutical products and treatments for disorders of the central nervous system and psychiatric diseases and disorders; Design and control of pharmacogenetic diagnostic tests for disorders and diseases of the central nervous system and psychiatric diseases and disorders; Design and control of pharmacogenetic tests, including the devising, compiling and testing of algorithms and mathematical systems for predicting response to a pharmaceutical product based on individual genetic profile; Scientific research related to pharmacogenetics; Research and advisory services relating to pharmaceuticals
Goods and ServicesMedical diagnostic services; Medical diagnostic testing relating to the human body, namely, analysis of samples to predict response of individuals to pharmaceutical products and treatments for disorders of the central nervous system and psychiatric diseases and disorders; Medical diagnostic testing relating to the human body, namely, analysis of samples to confirm diagnosis of diseases and disorders of the central nervous system and psychiatric diseases and disorders; Medical clinical services, namely, analysis of samples of DNA, RNA and bodily tissues to prescribe the prescribe the most efficient and/or efficacious pharmaceutical product to the patient; Medical clinical services, namely, the taking of samples of bodily tissues for analysis in connection with the prescription of pharmaceuticals or other medical treatment; Medical and scientific research in the nature of conducting clinical trials; Compilation of medical reports relating to prediction of response of individuals to pharmaceutical products and treatments for disorders of the central nervous system and psychiatric diseases and disorders; Compilation of medical reports relating to confirmation of diagnosis of diseases and disorders of the body, and prescription of most efficient and efficacious pharmaceutical product or method for treatment thereof; Compilation of medical reports as a resource of phenotypic and genotypic data relating to diseases and disorders of the central nervous system and psychiatric diseases and disorders; Conducting medical examinations for diagnosis and treatments of disease; Testing and profiling of pharmaceutical preparations and treatments for medical purposes; Computer aided diagnostic testing services relating to the human body
Pseudo MarkTHERA BANK

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 25, 2008
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 25, 2008
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTheraGenetics Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDenmark Hill, London SE58AF
GB

Trademark Events


Event DateEvent Description
Monday, January 4, 2010ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, January 4, 2010ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, June 1, 2009NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, June 1, 2009INQUIRY TO SUSPENSION E-MAILED
Monday, June 1, 2009SUSPENSION INQUIRY WRITTEN
Monday, June 1, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, May 28, 2009ASSIGNED TO LIE
Friday, November 28, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, November 28, 2008LETTER OF SUSPENSION E-MAILED
Friday, November 28, 2008SUSPENSION LETTER WRITTEN
Tuesday, November 18, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 18, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 18, 2008ASSIGNED TO LIE
Wednesday, November 5, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 5, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 5, 2008NON-FINAL ACTION E-MAILED
Monday, May 5, 2008NON-FINAL ACTION WRITTEN
Tuesday, April 29, 2008ASSIGNED TO EXAMINER
Saturday, January 26, 2008NOTICE OF PSEUDO MARK MAILED
Friday, January 25, 2008NEW APPLICATION ENTERED IN TRAM